BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31555767)

  • 1. Pro-Calcitonin, Erythrocyte Sedimentation Rate and C - reactive Protein in Predicting Diabetic Foot Ulcer Characteristics; a Cross Sectional Study.
    Hadavand F; Amouzegar A; Amid H
    Arch Acad Emerg Med; 2019; 7(1):37. PubMed ID: 31555767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of procalcitonin, erythrocyte sedimentation rate (ESR), quantitative C-reactive protein (CRP) and clinical findings associated with osteomyelitis in patients with diabetic foot.
    Soleimani Z; Amighi F; Vakili Z; Momen-Heravi M; Moravveji SA
    Hum Antibodies; 2021; 29(2):115-121. PubMed ID: 33749641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Value of Erythrocyte Sedimentation Rate and C Reactive Protein in detecting Diabetic Foot Osteomyelitis; a Cross-sectional Study.
    Moallemi SK; Niroomand M; Tadayon N; Forouzanfar MM; Fatemi A
    Arch Acad Emerg Med; 2020; 8(1):e71. PubMed ID: 33134967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can procalcitonin be an accurate diagnostic marker for the classification of diabetic foot ulcers?
    Jonaidi Jafari N; Safaee Firouzabadi M; Izadi M; Safaee Firouzabadi MS; Saburi A
    Int J Endocrinol Metab; 2014 Jan; 12(1):e13376. PubMed ID: 24696696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What are the Optimal Cutoff Values for ESR and CRP to Diagnose Osteomyelitis in Patients with Diabetes-related Foot Infections?
    Lavery LA; Ahn J; Ryan EC; Bhavan K; Oz OK; La Fontaine J; Wukich DK
    Clin Orthop Relat Res; 2019 Jul; 477(7):1594-1602. PubMed ID: 31268423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update of biomarkers to diagnose diabetic foot osteomyelitis: A meta-analysis and systematic review.
    Ansert EA; Tarricone AN; Coye TL; Crisologo PA; Truong D; Suludere MA; Lavery LA
    Wound Repair Regen; 2024 Apr; ():. PubMed ID: 38566503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The performance of serum inflammatory markers for the diagnosis and follow-up of patients with osteomyelitis.
    Michail M; Jude E; Liaskos C; Karamagiolis S; Makrilakis K; Dimitroulis D; Michail O; Tentolouris N
    Int J Low Extrem Wounds; 2013 Jun; 12(2):94-9. PubMed ID: 23667102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A New Inflammatory Marker of Clinical and Diagnostic Importance in Diabetic Foot Infection: Systemic Immune-Inflammation Index.
    Ozer Balin S; Ozcan EC; Uğur K
    Int J Low Extrem Wounds; 2022 Oct; ():15347346221130817. PubMed ID: 36221931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of procalcitonin as a marker of diabetic foot ulcer infection.
    Massara M; De Caridi G; Serra R; Barillà D; Cutrupi A; Volpe A; Cutrupi F; Alberti A; Volpe P
    Int Wound J; 2017 Feb; 14(1):31-34. PubMed ID: 26511007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of inflammatory markers in diagnosing infected diabetic foot ulcers and diabetic foot osteomyelitis: Systematic review and meta-analysis.
    Sharma H; Sharma S; Krishnan A; Yuan D; Vangaveti VN; Malabu UH; Haleagrahara N
    PLoS One; 2022; 17(4):e0267412. PubMed ID: 35476639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of inflammatory markers to diagnose and monitor diabetic foot osteomyelitis.
    Van Asten SA; Nichols A; La Fontaine J; Bhavan K; Peters EJ; Lavery LA
    Int Wound J; 2017 Feb; 14(1):40-45. PubMed ID: 26634954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The infected diabetic foot: Modulation of traditional biomarkers for osteomyelitis diagnosis in the setting of diabetic foot infection and renal impairment.
    Coye TL; Crisologo PA; Suludere MA; Malone M; Oz OK; Lavery LA
    Int Wound J; 2024 Mar; 21(3):e14770. PubMed ID: 38484740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Procalcitonin more superior to hs-CRP in the diagnosis of infection in diabetic foot ulcer?
    Zakariah NA; Bajuri MY; Hassan R; Ismail Z; Md Mansor M; Othman H; Nasuruddin DN
    Malays J Pathol; 2020 Apr; 42(1):77-84. PubMed ID: 32342934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentraxin-3 and Other Inflammatory Markers for an Infected Diabetic Foot Ulcer Diagnosis: A Prospective Study.
    Ardelean A; Balta DF; Neamtu C; Neamtu AA; Rosu M; Pilat L; Moldovan S; Tarta C; Totolici B
    Diagnostics (Basel); 2023 Jul; 13(14):. PubMed ID: 37510110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin as a diagnostic aid in diabetic foot infections.
    Uzun G; Solmazgul E; Curuksulu H; Turhan V; Ardic N; Top C; Yildiz S; Cimsit M
    Tohoku J Exp Med; 2007 Dec; 213(4):305-12. PubMed ID: 18075234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of circulatory procalcitonin as a biomarker reflecting inflammation among South Indian diabetic foot ulcers.
    Umapathy D; Dornadula S; Rajagopalan A; Murthy N; Mariappanadar V; Kesavan R; Kunka Mohanram R
    J Vasc Surg; 2018 Apr; 67(4):1283-1291.e2. PubMed ID: 28736121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Procalcitonin (PCT) - Is there a Role as an Early Biomarker in Infected Diabetic Foot Ulcer (IDFU) Patients?
    Omar J; Ahmad NS; Che-Soh N; Wan-Azman WN; Yaacob NM; Abdul-Ghani NS; Abdullah MR
    Malays Orthop J; 2023 Jul; 17(2):62-69. PubMed ID: 37583519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of procalcitonin in infected diabetic foot ulcer.
    Park JH; Suh DH; Kim HJ; Lee YI; Kwak IH; Choi GW
    Diabetes Res Clin Pract; 2017 Jun; 128():51-57. PubMed ID: 28448892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can procalcitonin predict bone infection in people with diabetes with infected foot ulcers? A pilot study.
    Mutluoğlu M; Uzun G; İpcioğlu OM; Sildiroglu O; Özcan Ö; Turhan V; Mutlu H; Yildiz S
    Diabetes Res Clin Pract; 2011 Oct; 94(1):53-6. PubMed ID: 21658786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of the diagnostic value of CRP:albumin ratio for osteomyelitis in patients with diabetic foot ulcers.
    Eren MA; Güneş AE; Ceylan MR; İncebıyık H; Aydın MS; Dusak A; Sabuncu T
    J Wound Care; 2022 Mar; 31(Sup3):S25-S28. PubMed ID: 35199563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.